Saly986336
ORANGE EKSTRAKLASA
Dołączył: 26 Sty 2011
Posty: 347
Przeczytał: 0 tematów
Ostrzeżeń: 0/5 Skąd: England
|
Wysłany: Śro 16:47, 09 Mar 2011 |
|
|
Background ,[link widoczny dla zalogowanych]
Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus,[link widoczny dla zalogowanych], but its effect on cardiovascular morbidity and mortality has not been determined.
Full Text of Background ...
Methods We conducted searches of the published literature, the Web site of the Food and Drug Administration,[link widoczny dla zalogowanych], and a clinical-trials registry maintained by the drug manufacturer (GlaxoSmithKline). Criteria for inclusion in our meta-analysis included a study duration of more than 24 weeks, the use of a randomized control group not receiving rosiglitazone,[link widoczny dla zalogowanych], and the availability of outcome data for myocardial infarction and death from cardiovascular causes. Of 116 potentially relevant studies,[link widoczny dla zalogowanych],[link widoczny dla zalogowanych], 42 trials met the inclusion criteria. We tabulated all occurrences of myocardial infarction and death from cardiovascular causes.
Full Text of Methods ...
Post został pochwalony 0 razy
|
|